The Histology Laboratory of the Laboratory of Pathology (LOP) is a core facility devoted to supporting the clinical activities of LOP. This consists of accessioning human tissues removed at surgery or in clinics, processing the tissues, preparing and staining slides for microscopy. Pathology residents are trained in techniques of gross dissection and learn to evaluate large and small specimens in preparation for microscopic evaluation. The lab also processes slides and blocks submitted from laboratories outside the NIH on NIH patients or non-NIH patients. Within the LOP, the Histology lab serves the Surgical Pathology, Hematopathology, Postmortem Pathology and Cytopathology sections as well as the Specialized Diagnostics Unit. To date during FY12, over 29,000 tissue blocks were prepared and over 101,000 slides were cut and stained. The laboratory processes a large variety of tissue specimens from NIH patients, including a wide variety of malignancies, AIDS-related diagnostic speciment, infections, and surveillance biopsies. Additionally, the laboratory processes case material sent in consultation or for review prior to protocol entry for patients in the Clinical Center. This fiscal year over 69,000 consult slides and 2400 blocks on over 4100 cases were received. Although about 95% of effort is devoted to clinical duties, the Histology Laboratory also performs recuts of tissue blocks and does some routine staining for research projects in NCI by arrangement. This activity is coordinated with the tissue research request function of Clinical Operations. The Histology Lab does not conduct primary research but supports the activities of many investigators.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Scientific Cores Intramural Research (ZIC)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Cancer Institute Division of Basic Sciences
Zip Code
Kleiner, David E; Chalasani, Naga P; Lee, William M et al. (2014) Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology 59:661-70
Russo, Mark W; Hoofnagle, Jay H; Gu, Jiezhun et al. (2014) Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network. Hepatology 60:679-86
Heller, T; Rotman, Y; Koh, C et al. (2014) Long-term therapy of chronic delta hepatitis with peginterferon alfa. Aliment Pharmacol Ther 40:93-104
Kleiner, David E; Berk, Paul D; Hsu, Jesse Y et al. (2014) Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study. Semin Liver Dis 34:98-107
Osinusi, Anuoluwapo; Meissner, Eric G; Lee, Yu-Jin et al. (2013) Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. JAMA 310:804-11
Gara, Naveen; Zhao, Xiongce; Kleiner, David E et al. (2013) Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 11:303-8.e1
Fuss, Ivan J; Friend, Julia; Yang, Zhiqiong et al. (2013) Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol 33:748-58
Oppenheimer, Ana Paula; Koh, Christopher; McLaughlin, Mary et al. (2013) Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases. World J Gastroenterol 19:115-21
Safar Zadeh, Elika; Lungu, Andreea O; Cochran, Elaine K et al. (2013) The liver diseases of lipodystrophy: the long-term effect of leptin treatment. J Hepatol 59:131-7
Noureddin, Mazen; Wright, Elizabeth C; Alter, Harvey J et al. (2013) Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis. Hepatology 58:1548-57

Showing the most recent 10 out of 21 publications